METHOD FOR PRODUCING MONOCOMPONENT-MICROFILAMENTS AND OBTAINING A NONWOVEN, WOVEN OR KNIT FABRIC COMPRISED OF THESE MICROFILAMENTS

Details for Australian Patent Application No. 2002228049 (hide)

Owner CARL FREUDENBERG KG

Inventors GROTEN, Robert; RIBOULET, Georges; REIBEL, Denis

Pub. Number AU-A-2002228049

PCT Pub. Number WO2002/057524

Priority 101 17 970.7 19.01.01 DE

Filing date 16 January 2002

Wipo publication date 30 July 2002

International Classifications

D01F 008/04 Conjugated, i.e. bi- or multicomponent, artificial filaments or the like - from synthetic polymers

D04H 001/46 Kinds or types of non-woven fabrics - by needling or like operations to cause entanglement of fibres

D01F 008/14 Conjugated, i.e. bi- or multicomponent, artificial filaments or the like - with at least one polyester as constituent

D01F 013/04 Recovery of starting material, waste material, or solvents during the manufacture of artificial filaments or the like

D04H 003/10 Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002228049

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228050-Fungicidal mixtures

2002228048-Urea derivatives as integrin alpha 4 antagonists